TORPENZ
NDC 0245-0825, Everolimus, tablet, from Upsher-Smith Laboratories, LLC.
- Product NDC
- 0245-0825
- Status
- Listed
- Labeler
- Upsher-Smith Laboratories, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214182
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0245-0825 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EVEROLIMUS10 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0245-0825-04 | 00245082504 | 28 BLISTER PACK in 1 CARTON (0245-0825-04) / 1 TABLET in 1 BLISTER PACK (0245-0825-89) |
| 0245-0825-30 | 00245082530 | 30 TABLET in 1 BOTTLE (0245-0825-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4c0075dd-a0a8-4dc4-be32-1be8383fbbdcNADAC price for package 00245082504
GET /v1/drugs/nadac/00245082504NADAC price for package 00245082530
GET /v1/drugs/nadac/00245082530
Use it
Look up 0245-0825 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0245-0825 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0245-0825. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.